USA - Bioavailability and Bioequivalence

This guide provides an overview of bioavailability and bioequivalence studies, which are crucial components in the support of Investigational New Drugs (INDs), New Drug Applications (NDAs), and NDA supplements. It explains the definitions of bioavailability and bioequivalence, how these studies are conducted and their purpose in drug development and post-approval stages.